science-product-detail
https://doi.org/10.3389/fendo.2021.630550
Low Prognosis by the POSEIDON Criteria in Women Undergoing Assisted Reproductive Technology: A Multicenter and Multinational Prevalence Study of Over 13,000 Patients
Sandro C. Esteves1*, Hakan Yarali2,3, Lan N. Vuong4,5,6, José F. Carvalho7, İrem Y. Özbek2, Mehtap Polat2, Ho L. Le4,5, Toan D. Pham4,5, and Tuong M. Ho4,5 on behalf of The POSEIDON Group †
Objective: To estimate the prevalence of low-prognosis patients according to the POSEIDON criteria using real-world data.
Design: Multicenter population-based cohort study.
Settings: Fertility clinics in Brazil, Turkey, and Vietnam.
Patients: Infertile women undergoing assisted reproductive technology using standard ovarian stimulation with exogenous gonadotropins.
Interventions: None.
Main outcome measures: Per-period prevalence rates of POSEIDON patients (overall, stratified by POSEIDON groups and by study center) and the effect of covariates on the probability that a patient be classified as “POSEIDON”.
Results: A total of 13,146 patients were included. POSEIDON patients represented 43.0% (95% confidence interval [CI] 42.0–43.7) of the studied population, and the prevalence rates varied across study centers (range: 38.6–55.7%). The overall prevalence rates by POSEIDON groups were 44.2% (group 1; 95% CI 42.6–45.9), 36.1% (group 2; 95% CI 34.6–37.7), 5.2% (group 3; 95% CI 4.5–6.0), and 14.4% (group 4; 95% CI: 13.3–15.6). In general, POSEIDON patients were older, had a higher body mass index (BMI), lower ovarian reserve markers, and a higher frequency of female factor as the primary treatment indication than non-POSEIDON patients. The former required larger doses of gonadotropin for ovarian stimulation, despite achieving a 2.5 times lower number of retrieved oocytes than non-POSEIDON patients. Logistic regression analyses revealed that female age, BMI, ovarian reserve, and a female infertility factor were relevant predictors of the POSEIDON condition.
Conclusions: The estimated prevalence of POSEIDON patients in the general population undergoing ART is significant. These patients differ in clinical characteristics compared with non-POSEIDON patients. The POSEIDON condition is associated with female age, ovarian reserve, BMI, and female infertility. Efforts in terms of diagnosis, counseling, and treatment are needed to reduce the prevalence of low-prognosis patients.
KEYWORDS:
Download
Similar articles
-
Review In vitro maturation versus in vitro fertilization in women with a high antral follicle count: a cost-effectiveness analysis
[ Sanne C Braam1, Vu N A Ho2, Toan D Pham2, Ben W Mol3, Madelon van Wely4, Lan N Vuong5 ]
Abstract...
-
Review Selecting euploid embryo for transfer by preimplantation genetic testing for aneuploidy improved clinical outcomes in patients with advanced maternal age
[ Le Thi Bich Phuong1,2, Vo Nguyen Thuc1,2, Pham Thieu Quan1,2, Le Hoang Anh1,2, Dang Quang Vinh1,2, Nguyen Thi Thuong Huyen3 ]
ObjectivesThis study aimed to investigate whether selecti...
- Review Standardizing definitions and reporting guidelines for the infertility core outcome set: an international consensus development study [ J M N Duffy 1 2, S Bhattacharya 3, S Bhattacharya 3, M Bofill 4, B Collura 5, C Curtis 6 7, J L H Evers 8, L C Giudice 9 10, R G Farquharson 11, S Franik 12, M Hickey 13, M L Hull 14, V Jordan 4, Y Khalaf 15, R S Legro 16, S Lensen 13, D Mavrelos 17, B W Mol 18, C Niederberger 19, E H Y Ng 20 21, L Puscasiu 22, S Repping 23 24, I Sarris 1, M Showell 25, A Strandell 26, A Vail 27, M van Wely 23, M Vercoe 25, N L Vuong 28, A Y Wang 29, R Wang 18, J Wilkinson 27, M A Youssef 30, C M Farquhar 4 25, Core Outcome Measure for Infertility Trials (COMMIT) initiative ]
Study question: Can consensus definitions for the core outcome set for inferti...
https://doi.org/10.1093/humrep/deaa243
- Review Endocrine requirements for oocyte maturation following hCG, GnRH agonist, and Kisspeptin during IVF treatment [ Ali Abbara 1, Tia Hunjan 1, Vu N. A. Ho 2, Sophie A. Clarke 1, Alexander N. Comninos 1, Chioma Izzi-Engbeaya 1, Tuong M. Ho 2, Geoffrey H. Trew 3, Artsiom Hramyka 4, Tom Kelsey 4, Rehan Salim 3, Peter Humaidan 5, Lan N. Vuong 2,6 and Waljit S. Dhillo 1 ]
Objective: The maturation of oocytes to acq...
- Review Impact of Polycystic Ovary Syndrome Phenotypes on in Vitro Fertilization Outcomes in Vietnamese Women: A Secondary Analysis of a Randomized Controlled Trial [ Vu N.A. Ho1,2, Toan D. Pham1,2, Hieu L.T. Hoang1 , Lan N. Vuong1,2,3 ]
Background: Polycystic ovary syndrome (PCOS) is diagnosed when ≥2 of the following symptoms are pr...
- Review Standardizing definitions and reporting guidelines for the infertility core outcome set: an international consensus development study [ J M N Duffy 1 2, S Bhattacharya 3, S Bhattacharya 3, M Bofill 4, B Collura 5, C Curtis 6 7, J L H Evers 8, L C Giudice 9 10, R G Farquharson 11, S Franik 12, M Hickey 13, M L Hull 14, V Jordan 4, Y Khalaf 15, R S Legro 16, S Lensen 13, D Mavrelos 17, B W Mol 18, C Niederberger 19, E H Y Ng 20 21, L Puscasiu 22, S Repping 23 24, I Sarris 1, M Showell 25, A Strandell 26, A Vail 27, M van Wely 23, M Vercoe 25, N L Vuong 28, A Y Wang 29, R Wang 18, J Wilkinson 27, M A Youssef 30, C M Farquhar 4 25, Core Outcome Measure for Infertility Trials (COMMIT) initiative ]